Astrazeneca PLC (NYSE:AZN) saw unusually-strong trading volume on Thursday . Approximately 4,913,698 shares traded hands during trading, an increase of 3% from the previous session’s volume of 4,763,181 shares.The stock last traded at $32.67 and had previously closed at $32.81.

A number of analysts recently commented on AZN shares. Argus upgraded shares of Astrazeneca PLC from a “hold” rating to a “buy” rating and set a $38.00 price target on the stock in a research note on Monday, August 29th. Bank of America Corp. restated a “buy” rating and set a $36.65 price target on shares of Astrazeneca PLC in a research note on Monday, July 18th. Cantor Fitzgerald restated a “buy” rating on shares of Astrazeneca PLC in a research note on Thursday, July 28th. Beaufort Securities restated a “hold” rating on shares of Astrazeneca PLC in a research note on Friday, August 26th. Finally, Shore Capital restated a “hold” rating on shares of Astrazeneca PLC in a research note on Tuesday, June 14th. Two analysts have rated the stock with a sell rating, eight have given a hold rating, eleven have issued a buy rating and two have issued a strong buy rating to the company. The company presently has an average rating of “Buy” and a consensus target price of $36.88.

The company’s 50-day moving average is $32.95 and its 200-day moving average is $30.09. The firm has a market cap of $84.27 billion and a P/E ratio of 38.07.

Astrazeneca PLC (NYSE:AZN) last posted its quarterly earnings data on Thursday, July 28th. The company reported $0.83 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.76 by $0.07. The business earned $5.60 billion during the quarter, compared to analysts’ expectations of $5.56 billion. The business’s quarterly revenue was down 4.0% compared to the same quarter last year. During the same period in the previous year, the business posted $1.21 EPS. On average, equities research analysts forecast that Astrazeneca PLC will post $2.97 earnings per share for the current year.

The company also recently declared a dividend, which will be paid on Monday, September 12th. Shareholders of record on Friday, August 12th will be issued a dividend of $0.44 per share. The ex-dividend date is Wednesday, August 10th.

AstraZeneca PLC (AstraZeneca) is a biopharmaceutical company. The Company focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of diseases in various therapy areas, including respiratory, inflammation, autoimmune disease (RIA), cardiovascular and metabolic disease (CVMD) and oncology, as well as in infection, neuroscience and gastrointestinal areas.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.